Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Psychopharmacology

• Publication date

  1999-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/026988119901300405PMID 10667612
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

  2009cited by this paper
• Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects

  2004cited by this paper
• Provocative tests with psychostimulant drugs in schizophrenia

  2004cited by this paper
• Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain

  1999cited by this paper
• Stability of [123I]IBZM SPECT measurement of amphetamine‐induced striatal dopamine release in humans

  1999cited by this paper
• Changes in striatal D2‐receptor density following chronic treatment with amphetamine as assessed with pet in nonhuman primates

  1999cited by this paper
• Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach

  1998cited by this paper
• Imaging dopamine transmission in schizophrenia. A review and meta-analysis.

  1998influential reference
• Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil.

  1998cited by this paper
• Glutamate Modulation of Dopamine Measured in Vivo with Positron Emission Tomography (PET) and 11C-Raclopride in Normal Human Subjects

  1998cited by this paper
• Brain abnormality in schizophrenia

  1998cited by this paper
• Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.

  1998cited by this paper
• Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study.

  1998cited by this paper
• Evidence for striatal dopamine release during a video game

  1998cited by this paper
• Non‐NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK‐801) induced hyperlocomotion and dopamine release in the nucleus accumbens

  1998cited by this paper
• Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine

  1998cited by this paper
• Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography

  1997cited by this paper
• Presynaptic dopaminergic function in the striatum of schizophrenic patients.

  1997cited by this paper
• Neurochemical Sensitization in the Pathophysiology of Schizophrenia: Deficits and Dysfunction in Neuronal Regulation and Plasticity

  1997cited by this paper
• Effect of reserpine‐induced depletion of synaptic dopamine on [11C]Raclopride binding to D2‐dopamine receptors in the monkey brain

  1997cited by this paper
• Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment.

  1997cited by this paper
• Turning off the signal: mechanisms that attenuate signaling by G protein-coupled receptors.

  1997cited by this paper
• Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.

  1997influential reference
• Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous Infusion

  1997cited by this paper
• Imaging D2 Receptor Occupancy by Endogenous Dopamine in Humans

  1997influential reference
• PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects.

  1997cited by this paper
• Endocytosis and recycling of G protein-coupled receptors.

  1997cited by this paper
• Microdialysis and SPECT measurements of amphetamine‐induced dopamine release in nonhuman primates

  1997influential reference
• Evaluation of d‐amphetamine effects on the binding of dopamine D‐2 receptor radioligand, 18F‐fallypride in nonhuman primates using positron emission tomography

  1997cited by this paper
• Ultrastructural localization of D1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervation.

  1996cited by this paper
• Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats.

  1996cited by this paper
• The Prefrontal Cortex Regulates the Basal Release of Dopamine in the Limbic Striatum: An Effect Mediated by Ventral Tegmental Area

  1996cited by this paper
• Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.

  1996cited by this paper
• Amphetamine‐Induced time‐dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: A microdialysis study in behaving rats

  1995cited by this paper
• Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia

  1995cited by this paper
• The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function.

  1995cited by this paper
• Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy.

  1995cited by this paper
• Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis

  1995cited by this paper
• Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

  1995cited by this paper
• SPECT imaging of striatal dopamine release after amphetamine challenge.

  1995influential reference
• Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents

  1995cited by this paper
• SPECT Quantification of [123I]Iomazenil Binding to Benzodiazepine Receptors in Nonhuman Primates: II. Equilibrium Analysis of Constant Infusion Experiments and Correlation with in vitro Parameters

  1994cited by this paper
• In vivo quantification of dopamine D2 receptor parameters in nonhuman primates with [123I]iodobenzofuran and single photon emission computerized tomography.

  1994cited by this paper
• Imaging endogenous dopamine competition with [11C]raclopride in the human brain

  1994cited by this paper
• D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines.

  1994cited by this paper
• No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis.

  1994cited by this paper
• D2 Dopamine Receptor Binding in the Basal Ganglia of Antipsychotic-Free Schizophrenic Patients

  1994cited by this paper
• SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms.

  1994cited by this paper
• Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.

  1994cited by this paper
• Elevated dopa decarboxylase activity in living brain of patients with psychosis.

  1994cited by this paper
• 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine

  1994cited by this paper
• Neurotransmitter regulation of dopamine neurons in the ventral tegmental area.

  1993cited by this paper
• Single photon emission tomography measurement of benzodiazepine receptor number and affinity in primate brain: a constant infusion paradigm with [123I]iomazenil.

  1993cited by this paper
• The pharmacology and neural circuitry of sensitization to psychostimulants.

  1993cited by this paper
• Evaluation of 5‐[18F]Fluoropropylepidepride as a potential pet radioligand for imaging dopamine D2 receptors

  1993cited by this paper
• Striatal binding of the PET ligand 11C‐raclopride is altered by drugs that modify synaptic dopamine levels

  1993influential reference
• Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies.

  1993cited by this paper
• Amphetamine‐stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates

  1992influential reference
• GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography

  1992cited by this paper
• Lack of a bimodal distribution of ventricular size in schizophrenia: a Gaussian mixture analysis of 1056 cases and controls.

  1991cited by this paper
• Effects of endogenous dopamine on measures of [18F]N‐methylspiroperidol binding in the basal ganglia: Comparison of simulations and experimental results from PET studies in baboons

  1991cited by this paper
• Effects of endogenous dopamine on kinetics of [3H]N‐methylspiperone and [3H]raclopride binding in the rat brain

  1991cited by this paper
• Dopamine in schizophrenia: a review and reconceptualization.

  1991influential reference
• Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus.

  1991cited by this paper
• Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity.

  1991cited by this paper
• Amphetamine induced decreases in (18F)‐N‐methylspiroperidol binding in the baboon brain using positron emission tomography (PET)

  1991cited by this paper
• Synaptic Concentration of Dopamine in the Mouse Striatum in Relationship to the Kinetic Properties of the Dopamine Receptors and Uptake Mechanism

  1991cited by this paper
• Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine--an in vivo dialysis study in freely moving rats.

  1990cited by this paper
• D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.

  1990cited by this paper
• Extracellular Concentrations of Cocaine and Dopamine Are Enhanced During Chronic Cocaine Administration

  1990cited by this paper
• Dopaminergic mechanisms in idiopathic and drug-induced psychoses.

  1990cited by this paper
• Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens

  1990cited by this paper
• Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo.

  1989cited by this paper
• Kinetic properties of the accumulation of 3H-raclopride in the mouse brain in vivo

  1989cited by this paper
• Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis

  1989cited by this paper
• Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: Implications for positron emission tomography of the human brain

  1989cited by this paper
• Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo.

  1989cited by this paper
• Kinetic properties of the in vivo accumulation of 3H-(−)-N-n-propylnorapomorphine in mouse brain

  1989cited by this paper
• Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.

  1989cited by this paper
• Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats.

  1988cited by this paper
• The current status of the dopamine hypothesis of schizophrenia.

  1988cited by this paper
• Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.

  1987cited by this paper
• Prediction of relapse in schizophrenia.

  1987cited by this paper
• A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.

  1987cited by this paper
• Dopamine receptors in brain and periphery.

  1987cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987influential reference
• Dopamine receptors and the dopamine hypothesis of schizophrenia

  1987cited by this paper
• Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.

  1986cited by this paper
• Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.

  1986cited by this paper
• Exogenous l-dopa alters spiroperidol binding, in vivo, in the mouse striatum.

  1986cited by this paper
• Methylphenidate challenge as a predictor of relapse in schizophrenia.

  1984cited by this paper
• CNS stimulants as tools in the study of schizophrenia

  1984cited by this paper
• A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

  1984cited by this paper
• Dopamine receptor changes in schizophrenia in relation to the disease process and movement disorder.

  1983cited by this paper
• In vivo binding of N-n-propylnorapomorphine in the rat brain: regional localization, quantification in striatum and lack of correlation with dopamine metabolism.

  1983cited by this paper
• d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia.

  1982cited by this paper
• Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor.

  1982cited by this paper
• Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors.

  1981cited by this paper
• Molecular pathology of schizophrenia: more than one disease process?

  1980cited by this paper
• Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats

  1980cited by this paper

• VTA-forebrain connectivity moderates adaptive behavior

  2026cites this paper
• Cannabidiol attenuates behavioral and electrophysiological changes in the MAM model of schizophrenia in male and female rats.

  2025cites this paper
• The Ventral Pallidum Innervates a Distinct Subset of Midbrain Dopamine Neurons

  2025cites this paper
• The Etiological Role of Impaired Neurogenesis in Schizophrenia: Interactions with Inflammatory, Microbiome and Hormonal Signaling

  2025cites this paper
• Inhibition of hippocampal or thalamic inputs to the nucleus accumbens reverses stress-induced alterations in dopamine system function

  2025cites this paper
• Age- and sex-dependent effects of stressors on activity of the nucleus reuniens of the thalamus.

  2025cites this paper
• 20 Years of Aberrant Salience in Psychosis: What Have We Learned?

  2025cites this paper
• Molecular and topographic mapping of antipsychotic effects: a meta-analysis of postsynaptic density proteins in animal models with translational implications

  2025cites this paper
• Mapping Neurochemical Signatures onto Brain Structure for Neurotransmitter-Informed Discrimination of Schizophrenia Patients from Healthy Controls

  2025cites this paper
• Correlation between desynchrony of hippocampal neural activity and hyperlocomotion in the model mice of schizophrenia and therapeutic effects of aripiprazole

  2024cites this paper
• Pioglitazone attenuates behavioral and electrophysiological dysfunctions induced by two-hit model of schizophrenia in adult rodent offspring.

  2024cites this paper
• NMDAR dysfunction and the regulation of dopaminergic transmission in schizophrenia.

  2024cites this paper
• Reduction of SynGAP-γ, disrupted splicing of Agap3, and oligodendrocyte deficits in Srrm2 mice, a genetic model of schizophrenia and neurodevelopmental disorder

  2024cites this paper
• Extrasynaptic Localization Is Essential for α5GABAA Receptor Modulation of Dopamine System Function

  2024cites this paper
• Excessive left anterior hippocampal and caudate activation in schizophrenia underlie cognitive underperformance in a virtual navigation task.

  2024cites this paper
• Kappa opioid receptor availability predicts severity of anhedonia in schizophrenia

  2024cites this paper
• Reduction of Grin2a in adolescent rat dopamine neurons confers a phenotype relevant to psychosis

  2024cites this paper
• D2/D3 dopamine supports the precision of mental state inferences and self-relevance of joint social outcomes

  2024cites this paper
• Dopamine mediates a directionally opposite correlation between empathy and the reinforcing effects of amphetamine and gambling in people with gambling disorder vs. healthy controls.

  2024cites this paper
• Persistent extrasynaptic hyperdopaminergia in the mouse hippocampus induces plasticity and recognition memory deficits reversed by the atypical antipsychotic sulpiride

  2023cites this paper
• Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment

  2023cites this paper
• A Bayesian predictive processing account of Othello syndrome in Parkinson’s disease

  2023cites this paper
• α5-GABAA Receptor Modulation Reverses Behavioral and Neurophysiological Correlates of Psychosis in Rats with Ventral Hippocampal Alzheimer’s Disease-like Pathology

  2023cites this paper
• GL-II-73, a Positive Allosteric Modulator of α5GABAA Receptors, Reverses Dopamine System Dysfunction Associated with Pilocarpine-Induced Temporal Lobe Epilepsy

  2023cites this paper
• Congenital blindness does not protect against a schizophrenia-related phenotype in rodents.

  2023cites this paper
• Platelet Serotonin Level: An Essential Role in Human Behavior, Stress Reaction and the Selection of Psychotropic Drugs

  2023cites this paper
• Brain-region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant mice.

  2023cites this paper
• Antipsychotic drug efficacy correlates with the modulation of D1 rather than D2 receptor-expressing striatal projection neurons

  2023cites this paper
• Extrasynaptic localization is essential for α5GABAA receptor modulation of dopamine system function

  2023cites this paper
• Aberrant Dopamine System Function in the Ferrous Amyloid Buthionine (FAB) Rat Model of Alzheimer’s Disease

  2023cites this paper
• Fifty years on: Serotonin and depression

  2023cites this paper
• Brain region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant mice

  2022cites this paper
• Hippocampal α5-GABAA Receptors Modulate Dopamine Neuron Activity in the Rat Ventral Tegmental Area

  2022cites this paper
• Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?

  2022cites this paper
• Dopamine, Psychosis, and Symptom Fluctuation: A Narrative Review

  2022cites this paper
• Sex Differences in Psychosis: Focus on Animal Models.

  2022cites this paper
• What Can We Learn from Animal Models to Study Schizophrenia?

  2022cites this paper
• Treatment-resistant schizophrenia: How far have we traveled?

  2022cites this paper
• Positive Allosteric Modulation of α5-GABAA Receptors Reverses Stress-Induced Alterations in Dopamine System Function and Prepulse Inhibition of Startle

  2022cites this paper
• Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics

  2022cites this paper
• Dopaminergic alterations in populations at increased risk for psychosis: a systematic review of imaging findings.

  2022cites this paper
• Four decades of mapping and quantifying neuroreceptors at work in vivo by positron emission tomography

  2022cites this paper
• Increased Presynaptic Dopamine Synthesis Capacity Is Associated With Aberrant Dopamine Neuron Activity in the Methylazoxymethanol Acetate Rodent Model Used to Study Schizophrenia-Related Pathologies

  2022cites this paper
• University of Birmingham Oxidative stress and the pathophysiology and symptom profile of schizophrenia spectrum disorders

  2021cites this paper
• Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in a rodent model of stress-induced psychosis

  2021cites this paper
• Modulating D1 rather than D2 receptor-expressing spiny-projection neurons corresponds to optimal antipsychotic effect

  2021cites this paper
• Pharmaco-Magnetic Resonance as a Tool for Monitoring the Medication-Related Effects in the Brain May Provide Potential Biomarkers for Psychotic Disorders

  2021cites this paper
• Highlighting the gaps in hazard and risk assessment of unregulated Endocrine Active Substances in surface waters: retinoids as a European case study

  2021cites this paper
• Epigenetic Mediation of AKT1 rs1130233’s Effect on Delta-9-Tetrahydrocannabinol-Induced Medial Temporal Function during Fear Processing

  2021cites this paper
• Monoamine Oxidase as a Potential Biomarker of the Efficacy of Treatment of Mental Disorders

  2021cites this paper
• Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders

  2021cites this paper
• Striatal dopamine mediates hallucination-like perception in mice

  2021cites this paper
• Peripubertal mGluR2/3 Agonist Treatment Prevents Hippocampal Dysfunction and Dopamine System Hyperactivity in Adulthood in MAM Model of Schizophrenia.

  2021cites this paper
• Kaleidoscope

  2021cites this paper
• Chronic Cerebral Toxoplasmosis Changes Brain Glutamate and D-Serine Levels, Impairs Startle Reflex But Not Social Preference in Mice

  2021cites this paper
• Social preference is maintained in mice with impaired startle reflex and glutamate/D-serine imbalance induced by chronic cerebral toxoplasmosis

  2021cites this paper
• Моноаминоксидаза как потенциальный биологический маркер эффективности терапии психических заболеваний

  2021cites this paper
• Orexin Modulation of VTA Dopamine Neuron Activity: Relevance to Schizophrenia

  2021cites this paper
• Psychotic disorders, dopaminergic agents and EEG/MEG resting-state functional connectivity: a systematic review.

  2020cites this paper
• Leveraging Basic Science for the Clinic-From Bench to Bedside.

  2020cites this paper
• Dopamine and Response to Antipsychotic Medication

  2020cites this paper
• Repeated administration of LPS exaggerates amphetamine-induced locomotor response and causes learning deficits in mice.

  2020cites this paper
• Lumateperone for the Treatment of Schizophrenia.

  2020cites this paper
• The mGluR2/3 agonist pomaglumetad methionil normalizes aberrant dopamine neuron activity via action in the ventral hippocampus

  2020cites this paper
• What you want may not be what you like: A test of the aberrant salience hypothesis in schizophrenia risk

  2020cites this paper
• The Topography of Striatal Dopamine and Symptoms in Psychosis: An Integrative Positron Emission Tomography and Magnetic Resonance Imaging Study

  2020cites this paper
• The Effect of Chronic Methamphetamine Treatment on Schizophrenia Endophenotypes in Heterozygous Reelin Mice: Implications for Schizophrenia

  2020cites this paper
• The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research

  2020cites this paper
• The Topography of Striatal Dopamine and Symptoms in Psychosis: An Integrative PET and MRI study

  2020cites this paper
• Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia.

  2020cites this paper
• A preliminary study to investigate resting state fMRI as a potential group differentiator for schizophrenia.

  2020cites this paper
• Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia

  2020cites this paper
• Joint Multi-modal Parcellation of the Human Striatum: Functions and Clinical Relevance

  2020cites this paper
• Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia

  2019cites this paper
• Basal ganglia volumetric changes in psychotic spectrum disorders.

  2019cites this paper
• Developing a dynamic model of metacognitive influences on anomalous experiences and functional outcome in young people with and without psychosis

  2019influential citation
• Enhanced Dopamine in Prodromal Schizophrenia (EDiPS): a new animal model of relevance to schizophrenia

  2019cites this paper
• Imaging Neuronal Pathways of the Rat Basal Ganglia System with 52Mn PET and MEMRI

  2019cites this paper
• Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms.

  2019cites this paper
• Adolescent stress contributes to aberrant dopamine signaling in a heritable rodent model of susceptibility.

  2019cites this paper
• Dopaminergic signaling of uncertainty and the aetiology of gambling addiction.

  2019cites this paper
• The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention.

  2019cites this paper
• Young spontaneously hypertensive rats (SHRs) display prodromal schizophrenia‐like behavioral abnormalities

  2019cites this paper
• Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat.

  2019cites this paper
• Striatal dopamine, functional connectivity, and salience processing in health and disease

  2019cites this paper
• Exploring the Dendritic Spine Pathology in a Schizophrenia-related Neurodevelopmental Animal Model.

  2019cites this paper
• Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality.

  2019cites this paper
• Non-Genetic Factors in Schizophrenia

  2019cites this paper
• The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study.

  2019cites this paper
• Mental Health and the Brain

  2019cites this paper
• The Bed Nucleus of the Stria Terminalis, Homeostatic Satiety, and Compulsions: What Can We Learn From Polydipsia?

  2019cites this paper
• Region specific knockdown of Parvalbumin or Somatostatin produces neuronal and behavioral deficits consistent with those observed in schizophrenia

  2019cites this paper
• Neurochemical evidence that cysteamine modulates amphetamine-induced dopaminergic neuronal activity in striatum by decreasing dopamine release: an in vivo microdialysis study in freely moving rats.

  2019cites this paper
• D-cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions Detailed Study Protocol Principal Investigator: Donald Goff, MD Purpose of the Study Specific Aims and Design: Antipsychotic-resistant delusions in schizophrenia are common, are often distressing, and increase the risk for inca

  2018cites this paper
• Activation of the motivation-related ventral striatum during delusional experience

  2018cites this paper
• Schizophrenia dimension-specific antipsychotic drug action and failure in amphetamine-sensitized psychotic-like rats.

  2018cites this paper
• Acute anxiety disorder, major depressive disorder, bipolar disorder and schizophrenia are related to different patterns of nigrostriatal and mesolimbic dopamine dysfunction

  2018cites this paper
• Neurobiological Determinants of Tobacco Smoking in Schizophrenia

  2018cites this paper
• Convergent Inputs from the Hippocampus and Thalamus to the Nucleus Accumbens Regulate Dopamine Neuron Activity

  2018cites this paper
• Maternal Vitamin D Prevents Abnormal Dopaminergic Development and Function in a Mouse Model of Prenatal Immune Activation

  2018cites this paper